2022 ESC Guidelines on cardio-oncology developed in collaboration with the European Hematology Association (EHA), the European Society for Therapeutic …

AR Lyon, T López-Fernández, LS Couch… - European Heart …, 2022 - academic.oup.com
ESC Guidelines e341 (1) the specific situation of the patient. In this respect, it is specified
that, unless otherwise provided for by national regulations, offlabel use of medication should …
被引用次数：1293 相关文章

[引用][C] 2022 ESC Guidelines on cardio-oncology developed in collaboration with the European Hematology Association (EHA), the European Society for Therapeutic …

AR Lyon, T López-Fernández, LS Couch… - EUROPEAN HEART …, 2022 - iris.unina.it

2022 ESC Guidelines on cardio-oncology developed in collaboration with the European Hematology Association (EHA), the European Society for Therapeutic …

AR Lyon, T López-Fernández, LS Couch… - European heart …, 2022 - boris.unibe.ch
BORIS Deutsch English Français Login BORIS Bern Open Repository and Information System
University of Bern Home Statistics 2022 ESC Guidelines on cardio-oncology developed in …

2022 ESC Guidelines on cardio-oncology developed in collaboration with the European Hematology Association (EHA), the European Society for Therapeutic …

AR Lyon, T López-Fernández, LS Couch… - European Heart …, 2022 - ora.ox.ac.uk
Downloaded from https://academic. oup. com/ehjcimaging/article/23/10/e333/6675075 by
Whitehead Library user on 03 February 2023 (1) the specific situation of the patient. In this …

2022 ESC Guidelines on cardio-oncology developed in collaboration with the European Hematology Association (EHA), the European Society for Therapeutic …

AR Lyon, T López-Fernández, LS Couch… - European Heart …, 2022 - researchportal.vub.be
2022 ESC Guidelines on cardio-oncology developed in collaboration with the European
Hematology Association (EHA), the European Society for Therapeutic Radiology and Oncology …

2022 ESC Guidelines on cardio-oncology developed in collaboration with the European Hematology Association (EHA), the European Society for Therapeutic …

AR Lyon, T López-Fernández… - European heart …, 2022 - pubmed.ncbi.nlm.nih.gov
2022 ESC Guidelines on cardio-oncology developed in collaboration with the European
Hematology Association (EHA), the European Society for Therapeutic Radiology and Oncology …

2022 ESC Guidelines on cardio-oncology developed in collaboration with the European Hematology Association (EHA), the European Society for Therapeutic …

AR Lyon, T López-Fernández, LS Couch… - European Heart …, 2022 - pure.au.dk
2022 ESC Guidelines on cardio-oncology developed in collaboration with the European
Hematology Association (EHA), the European Society for Therapeutic Radiology and Oncology …
[HTML] ugent.be

[HTML][HTML] 2022 ESC guidelines on cardio-oncology developed in collaboration with the European Hematology Association (EHA), the European Society for Therapeutic …

AR Lyon, T López-Fernández, LS Couch… - EUROPEAN HEART …, 2022 - biblio.ugent.be
2022 ESC guidelines on cardio-oncology developed in collaboration with the European
Hematology Association (EHA), the European Society for Therapeutic Radiology and Oncology …

2022 ESC Guidelines on cardio-oncology developed in collaboration with the European Hematology Association (EHA), the European Society for Therapeutic …

A Lyon, T López-Fernández, L Couch… - European Heart …, 2022 - hal.science
2022 ESC Guidelines on cardio-oncology developed in collaboration with the European
Hematology Association (EHA), the European Society for Therapeutic Radiology and Oncology …

2022 ESC Guidelines on cardio-oncology developed in collaboration with the European Hematology Association (EHA), the European Society for Therapeutic …

AR Lyon, T López-Fernánde, LS Couch… - European Heart …, 2022 - research.rug.nl
ESC and updated. The Task Force received its entire financial support from the ESC without
any involvement from the healthcare industry. The ESC CPG supervises and coordinates the …